SDF-1 treatment also transactivates Her2 via CXCR4 present on cultured human breast and prostate carcinoma cells in a paracrine fashion (Cabioglu et al, 2005; Chinni et al, 2008). This evidence concerns the gene CXCR4 and prostate carcinoma.